1)The cardiac Arrhythmia Suppression Trial(CAST)Investigators:Preliminary report;Effect of encainide and flecainide on mortarity in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 321:406-412, 1989
2)Connolly SJ, et al:Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials;AVID, CASH, and SIDS studies. Antiarrhythmics vs implantable defibrillator study. Cardiac Arrest Study Hamburg. Canadian implantable defibrillator study. Eur Heart J 21:2071-2078, 2000
3)Moss AJ, et al:Improved survival with implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 335:1933-1940, 1996
4)Moss AJ, et al:Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346:877-883, 2002
5)Bardy GH, et al:Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352:225-237, 2005
6)Cleland JG, et al:The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352:1594-7, 2005
7)Bristow M, et al:Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350:2140-2150, 2004